ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,317 | -18.8% | 1,526 | 0.0% | 0.00% | – |
Q2 2023 | $10,239 | +19590.4% | 1,526 | -74.2% | 0.00% | – |
Q1 2023 | $52 | +15.6% | 5,926 | 0.0% | 0.00% | – |
Q4 2022 | $45 | -99.9% | 5,926 | 0.0% | 0.00% | – |
Q3 2022 | $46,000 | -4.2% | 5,926 | -0.9% | 0.00% | – |
Q2 2022 | $48,000 | +2300.0% | 5,978 | +3683.5% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 158 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -76.9% | 158 | -57.9% | 0.00% | – |
Q3 2021 | $13,000 | -90.7% | 375 | -89.0% | 0.00% | -100.0% |
Q2 2021 | $140,000 | +1.4% | 3,416 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $138,000 | -31.7% | 3,416 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $202,000 | – | 3,416 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |